Artal Group S.A. Alector, Inc. Transaction History

Artal Group S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$10.54 - $24.96 $2.11 Million - $4.99 Million	-200,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$21.87 - $33.11 $1.09 Million - $1.66 Million	-50,000 Reduced 20.0%	200,000 $4.89 Million
Q1 2020 May 14, 2020	BUY	$16.25 - $35.28 $406,250 - $882,000	25,000 Added 11.11%	250,000 $6.03 Million
Q2 2019 Aug 09, 2019	SELL	$16.26 - $26.42 $406,500 - $660,500	-25,000 Reduced 10.0%	225,000 $4.28 Million
Q1 2019 May 10, 2019	BUY	$15.97 - $22.5 $3.99 Million - $5.63 Million	250,000 New	250,000 $4.68 Million

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $156M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.